Lyell Reports 91% Overall Response Rate in 3L+ Ronde-Cel Cohort
Lyell reported a 91% overall response rate and 77% complete response rate among 44 Day 84-evaluable patients in its 3L+ trial. In the 2L cohort, rates were 95% and 76% among 37 evaluable patients. Updated data are expected at ASH 2026.
Lyell reported 91% overall response and 77% complete response rates among 44 Day 84-evaluable patients in its 3L+ trial; in the 2L cohort, rates were 95% and 76% among 37 evaluable patients. Updated data are expected at ASH 2026.Material DetailsContext by AI AnalystThis is an interim clinical updat…